PlainPharmaWatch
CMS PY 2024 Company profile Open Payments data

MICROVENTION, INC.

MICROVENTION, INC. reported $8.4M in payments to physicians and teaching hospitals across 5,506 transactions in CMS Open Payments PY 2024.

Pharmaceutical payment transparency data for MICROVENTION, INC.. Ranked #190 of 1,797 companies by total payments. Source: CMS Open Payments, Program Year 2024.

Payment Overview

Total Payments

$8.4M

0.1% of all payments

Transactions

5,506

$1.5K avg

Recipients

4,846

$1.7K avg

Industry Rank

#190

of 1,797 companies

What the Data Shows for MICROVENTION, INC.

In Program Year 2024, MICROVENTION, INC. reported $8,388,894.36 in payments to 4,846 physicians and teaching hospitals across 5,506 individual transactions — an average of $1.5K per transaction and $1.7K per recipient. That total places MICROVENTION, INC. at rank #190 out of 1,797 companies in the CMS Open Payments database, representing 0.1% of all industry payments reported nationwide for the year. Payment volume at this scale is characteristic of manufacturers with broad prescriber engagement, active clinical research programs, or patented therapies generating ongoing royalty obligations.

The payment mix for MICROVENTION, INC. spans 7 distinct categories defined by CMS — including general payments (consulting, speaker fees, meals, travel), research payments tied to clinical trials, and ownership or investment interests. The largest single category is "Compensation for Services Other Than Consulting" at $1.9M, accounting for 22.2% of the company's reported total and 1,046 transactions. This distribution matters because different payment types carry different regulatory and ethical implications: research funding supports clinical development, while general payments like meals and speaker fees have been studied for their correlation with prescribing patterns in peer-reviewed journals such as JAMA Internal Medicine.

Recipient concentration is another useful lens. The top 5 recipients of payments from MICROVENTION, INC. received $0.00 combined — 0.0% of the company's total — with the remaining 100.0% distributed across the rest of the 4,846 recipients. A relatively distributed top-5 share suggests broader engagement across the prescriber community rather than concentration among a handful of high-value relationships. All figures above are drawn directly from the CMS Open Payments Public Use Files for PY2024 and are disclosed under the Physician Payments Sunshine Act; this page summarizes reported financial transfers and does not represent medical advice or judgment about individual prescribing decisions.

Payment Breakdown by Type

MICROVENTION, INC. made 7 types of payments. "Compensation for Services Other Than Consulting" accounts for 22.2%.

Compensation for Services Other Than Consulting $1.9M

22.2% · 1,046 transactions

Consulting Fee $838.9K

10.0% · 283 transactions

Travel and Lodging $384.1K

4.6% · 1,011 transactions

Food and Beverage $163.8K

2.0% · 2,472 transactions

Space Rental or Facility Fees $105.7K

1.3% · 30 transactions

Grant $72.5K

0.9% · 3 transactions

Education $595.00

0.0% · 1 transactions

Payment Type Amount Transactions
Compensation for Services Other Than Consulting $1.9M 1,046
Consulting Fee $838.9K 283
Travel and Lodging $384.1K 1,011
Food and Beverage $163.8K 2,472
Space Rental or Facility Fees $105.7K 30
Grant $72.5K 3
Education $595.00 1

Payment Size Analysis

Average transaction size: $1.5K. Average per recipient: $1.7K.

Total Amount

$8,388,894.36

Avg per Transaction

$1.5K

Avg per Recipient

$1.7K

Payment Transparency Context

The Physician Payments Sunshine Act (part of the Affordable Care Act) requires pharmaceutical and medical device manufacturers to report payments and transfers of value to physicians and teaching hospitals. These payments can include consulting fees, research grants, speaker fees, food and beverages, travel, royalties, and other forms of compensation.

Industry Total (2024)

$13.3B

across 1,797 companies

MICROVENTION, INC. Share

0.1%

#190 by total payments

Frequently Asked Questions

How much did MICROVENTION, INC. pay to physicians and hospitals in 2024?
MICROVENTION, INC. made $8,388,894.36 in payments to physicians and hospitals in Program Year 2024, across 5,506 individual transactions. This represents 0.1% of all industry payments reported to CMS Open Payments.
How many physicians received payments from MICROVENTION, INC.?
MICROVENTION, INC. made payments to 4,846 physicians and teaching hospitals in 2024. The average payment per recipient was $1.7K.
What types of payments did MICROVENTION, INC. make?
MICROVENTION, INC. made 7 different types of payments. The largest category was "Compensation for Services Other Than Consulting" at $1.9M, representing 22.2% of all payments.
How does MICROVENTION, INC. rank among pharmaceutical companies?
MICROVENTION, INC. ranks #190 out of 1,797 companies by total payment amount in the CMS Open Payments database for 2024.
What is the average payment size from MICROVENTION, INC.?
The average transaction from MICROVENTION, INC. was $1.5K in 2024. The company made 5,506 total transactions to 4,846 recipients.
Are the top recipients concentrated for MICROVENTION, INC.?
The top 5 recipients received $0.00 from MICROVENTION, INC., representing 0.0% of the company's total payments. Payments are relatively well-distributed across recipients.
Where does the payment data for MICROVENTION, INC. come from?
This data comes from the CMS Open Payments program (Sunshine Act), which requires pharmaceutical and medical device companies to report payments and transfers of value to physicians and teaching hospitals. The data covers Program Year 2024.

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.3B across 1,797 companies.

Related

Data sourced from official U.S. government datasets. See our methodology for details. Retrieved and formatted by PlainPharmaWatch Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.